Valuation check: NMRD's profit margin is 405.33%, above the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2023
Trailing 12 months ending Dec 2023
Nemaura Medical (NMRD) currently reports a profit margin of 405.33% as of December 2023. That compares with -4938.27% in the prior-year period — up 108.2% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Nemaura Medical's profit margin history and peer comparisons.
Nemaura Medical's profit margin increased from -4938.27% to 405.33% — a 108.2% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Nemaura Medical's profit margin of 405.33% is higher than the Healthcare sector average of 13.89%. That is roughly 2817.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Nemaura Medical's current 405.33% should be judged against Healthcare norms (sector average: 13.89%) and against NMRD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 405.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.